CDKN1A and familial pancreatic carcinoma: While entinostat alone inhibited the expression of cell cycle proteins, its combination with decitabine (DNMTi) in pancreatic cancer increased expression of p21 to reinstitute cell cycle control and inhibit tumor growth, likely due to increased acetylation of histone H3 and demethylation of the p21 promoter (86).